EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional Characterization of p.(Arg160Gln) PCSK9 Variant Accidentally Found in a Hypercholesterolemic Subject

Asier Larrea-Sebal iD, Chiara Trenti, Shifa Jebari-Benslaiman, Stefano Bertolini, Sebastiano Calandra, Emanuele A Negri iD, Efrem Bonelli, Asier Benito-Vicente, Leire Uraga-Gracianteparaluceta, César Martín iD, Tommaso Fasano

International Journal of Molecular Sciences · 07.02.2023 · 24 (4) · 3330

DOI: 10.3390/ijms24043330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.02.2023. Verfasst von Asier Larrea-Sebal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080 Bilbao, Spain. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Hyperlipoproteinemia Type II. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basque Government, Grupos Consolidados Gobierno Vasco 2021, PIF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial hypercholesterolaemia (FH) is an autosomal dominant dyslipidaemia, characterised by elevated LDL cholesterol (LDL-C) levels in the blood. Three main genes are involved in FH diagnosis: LDL receptor (LDLr), Apolipoprotein B (APOB) and Protein convertase subtilisin/kexin type 9 (PCSK9) with genetic mutations that led to reduced plasma LDL-C clearance. To date, several PCSK9 gain-of-function (GOF) variants causing FH have been described based on their increased ability to degrade LDLr. On the other hand, mutations that reduce the activity of PCSK9 on LDLr degradation have been described as loss-of-function (LOF) variants. It is therefore important to functionally characterise PCSK9 variants in order to support the genetic diagnosis of FH. The aim of this work is to functionally characterise the p.(Arg160Gln) PCSK9 variant found in a subject suspected to have FH. Different techniques have been combined to determine efficiency of the autocatalytic cleavage, protein expression, effect of the variant on LDLr activity and affinity of the PCSK9 variant for the LDLr. Expression and processing of the p.(Arg160Gln) variant had a result similar to that of WT PCSK9. The effect of p.(Arg160Gln) PCSK9 on LDLr activity is lower than WT PCSK9, with higher values of LDL internalisation (13%) and p.(Arg160Gln) PCSK9 affinity for the LDLr is lower than WT, EC50 8.6 ± 0.8 and 25.9 ± 0.7, respectively. The p.(Arg160Gln) PCSK9 variant is a LOF PCSK9 whose loss of activity is caused by a displacement of the PCSK9 P’ helix, which reduces the stability of the LDLr-PCSK9 complex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9Hyperlipoproteinemia Type IIHumansCholesterol, LDLSubtilisinMutationMutant ProteinsReceptors, LDL

Stichwörter der Autor:innen

GOFLOFPCSK9activitycharacterisationfamilial hypercholesterolemia

Substanzen

PCSK9 protein, humanProprotein Convertase 9Cholesterol, LDLSubtilisinMutant ProteinsReceptors, LDL

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48080 Bilbao, Spain.
  • Department of Molecular Biophysics, Biofisika Institute, University of Basque Country and Consejo Superior de Investigaciones Científicas (UPV/EHU, CSIC), 48940 Leioa, Spain.
  • Fundación Biofisika Bizkaia, 48940 Leioa, Spain.
  • Department of Internal Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.
  • Department of Internal Medicine, University of Genova, 16132 Genova, Italy.
  • Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.

ORCID-Profile: Asier Larrea-Sebal, Emanuele A Negri, César Martín

Förderung

  • Basque Government
  • Grupos Consolidados Gobierno Vasco 2021
  • PIF
  • Fundación Biofísica Bizkaia
  • University of the Basque Country

Zitieren

APA

Larrea-Sebal, A., Trenti, C., Jebari-Benslaiman, S., Bertolini, S., Calandra, S., Negri, E. A., Bonelli, E., Benito-Vicente, A., Uraga-Gracianteparaluceta, L., Martín, C., & Fasano, T. (2023). Functional Characterization of p.(Arg160Gln) PCSK9 Variant Accidentally Found in a Hypercholesterolemic Subject. International Journal of Molecular Sciences, 24(4), 3330. https://doi.org/10.3390/ijms24043330

Vancouver

Larrea-Sebal A, Trenti C, Jebari-Benslaiman S, Bertolini S, Calandra S, Negri EA, et al. Functional Characterization of p.(Arg160Gln) PCSK9 Variant Accidentally Found in a Hypercholesterolemic Subject. International Journal of Molecular Sciences. 2023;24(4):3330. doi:10.3390/ijms24043330

BibTeX
@article{LarreaSebal2023,
  author = {Larrea-Sebal, Asier and Trenti, Chiara and Jebari-Benslaiman, Shifa and Bertolini, Stefano and Calandra, Sebastiano and Negri, Emanuele A and Bonelli, Efrem and Benito-Vicente, Asier and Uraga-Gracianteparaluceta, Leire and Martín, César and Fasano, Tommaso},
  title = {Functional Characterization of p.(Arg160Gln) PCSK9 Variant Accidentally Found in a Hypercholesterolemic Subject},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3330},
  doi = {10.3390/ijms24043330}
}
Kostenlos starten →